PBMs launch counterattack following Trump administration’s plan to end drug rebates

Pharmacy benefit managers are hitting back against critics who blame them for rising drug prices, as the system they use to negotiate rebates on drugs hangs in the balance.  The Pharmaceutical Care Management Association this week launched a campaign called #OnYourRxSide, which aims to education consumers about the role PBMs play in their health benefits and the role they play in bringing down costs at the pharmacy counter. “PBMs have an established and successful track record of implementing consumer-friendly, market-based tools, such as negotiating with drug manufacturers, to reduce costs for consumers,” JC Scott, president and CEO of the association, said in a statement.